<SEC-DOCUMENT>0001493152-21-001316.txt : 20210119
<SEC-HEADER>0001493152-21-001316.hdr.sgml : 20210119
<ACCEPTANCE-DATETIME>20210119161510
ACCESSION NUMBER:		0001493152-21-001316
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210119
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210119
DATE AS OF CHANGE:		20210119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONVERSION LABS, INC.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39785
		FILM NUMBER:		21535653

	BUSINESS ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(866) 351-5907

	MAIL ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immudyne, Inc.
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): January 19, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>CONVERSION
LABS, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-39785</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>76-0238453</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
        or other jurisdiction</B></FONT></P>
        <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
        incorporation)</B></FONT></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission</B></FONT></P>
        <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
        Number)</B></FONT></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
        Employer</B></FONT></P>
        <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>800
Third Avenue, Suite 2800</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>New
York, NY 10022</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
of principal executive offices, including zip code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>(866)
351-5907</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Registrant&rsquo;s
telephone number, including area code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CVLB</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nasdaq Stock Market LLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
&sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Item
    2.02</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
    of Operations and Financial Condition.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 19, 2021, Conversion Labs, Inc. (the &ldquo;Company&rdquo;) issued a press release announcing preliminary unaudited financial
results for the fourth quarter and full year ended December 31, 2020. A copy of the press release is included as Exhibit 99.1
to this report and is incorporated by reference into this Item 2.02.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01. Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)
Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONVERSION
    LABS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    January 19, 2021</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Justin Schreiber</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
    Schreiber Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 51; width: 350">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion
Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEW
YORK, NY, January 19, 2021 <FONT STYLE="background-color: white">&mdash;</FONT> <U>Conversion Labs, Inc</U>.</B> (NASDAQ: CVLB),
a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter and full year
ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R<FONT STYLE="background-color: white">evenue
for the fourth quarter </FONT>is expected to total <FONT STYLE="background-color: white">$13.6 million,</FONT> up 265% from <FONT STYLE="background-color: white">$3.7
million </FONT>in <FONT STYLE="background-color: white">the fourth quarter of 2019</FONT>. Revenue for the full year is expected
to total <FONT STYLE="background-color: white">$38.0 million</FONT>, up 205% from $12.5 million in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;Our
strong performance in 2020 demonstrated our ability to provide accessible healthcare to an increasing number of patients across
the country,&rdquo; stated Conversion Labs CEO, Justin Schreiber. &ldquo;We ended the year exceptionally strong, with December
revenues hitting a monthly record of $5.1 million, up 321% over December of last year. In fact, December 2020 alone eclipsed the
whole of the fourth quarter of 2019.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;Given
our extensive telehealth platform buildout in </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019<FONT STYLE="background-color: white">,
we were prepared when the breakout of the COVID-19 pandemic suddenly accelerated the consumer shift from traditional healthcare
to telemedicine,&rdquo; continued Schreiber. &ldquo;Conversion Labs now has a strong foundation for growth with a differentiated
business model that offers patients convenient and affordable access to healthcare services, prescriptions and over-the-counter
medications.&rdquo;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Annual
recurring revenue (ARR) generated by subscriptions reached $26.0 million by the end of the year, up 525% compared to the end of
2019 (see description of ARR, below).</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARR increased
by more than $3.0 million from November to December&mdash;another record-setting monthly gain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Conversion
Labs&rsquo; head of corporate development, Corey Deutsch, commented: &ldquo;Conversion Labs is playing an important role in making
healthcare accessible to now more than 250,000 patients nationwide. We believe our growth in ARR and continued rapid expansion
of this customer base demonstrates strong satisfaction with our products and services, and we expect it to further strengthen
as we execute our strategic growth objectives in 2021.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We&rsquo;re
excited about the recent relaunch of our proprietary <U>Shapiro MD</U> hair products for men and women under a new subscription-based
model,&rdquo; continued Deutsch. &ldquo;We expect this to drive greater customer retention similar to the strong results we&rsquo;ve
been seeing with our <U>Rex MD</U> subscription-based model introduced earlier this year. Subscription-based revenue provides
us great advantages, including improved forward visibility and lowered overall cost of customer acquisition.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Schreiber
added: &ldquo;Looking ahead in 2021, we expect our momentum to continue to build, driven by our expanding professional team and
growing suite of telehealth brands</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Convenience,
affordability and health security have become increasingly important to our patients, and this is where we believe Conversion
Labs excels beyond anyone else in the industry. We also believe we&rsquo;re still very much in the early stages of our growth
as a leading direct-to-consumer telemedicine business, so we expect 2021 to be our biggest year yet.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Conversion Labs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Labs, Inc. is a leading telemedicine company with a portfolio of online direct-to-consumer brands. The company combines virtual
medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers
telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn more, visit <U>Conversionlabs.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
Recurring Revenue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Labs calculates annual recurring revenue (ARR) by multiplying by 12 the monthly sum of revenue attributed exclusively to automatic
subscription sales from customers that are engaged in the company&rsquo;s rebill structure for the brands of Shapiro MD, Rex MD
and PDFSimpli. In the company&rsquo;s calculation of ARR, it does not consider sales from customers that repurchase its products
themselves in the company&rsquo;s checkout pages, Amazon Marketplace or through assistance of the company&rsquo;s customer service
representatives, since those sales have a marginal advertising/marketing expense associated with the respective sale. The company
also does not consider the revenue attributed to the initial purchase upon acquisition of the respective customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Cautions Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects &mdash;
both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these
forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations.
Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements
contained in this news release may be identified by the use of forward-looking words such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;should,&rdquo; &ldquo;planned,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;intend,&rdquo;
&ldquo;estimated,&rdquo; and &ldquo;potential,&rdquo; among others. Important factors that could cause actual results to differ
materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports
or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements
attributable to Conversion Labs, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary
language.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Labs</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Juan
Manuel Pi&ntilde;eiro Dagnery<BR>
CFO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email
Contact</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
and Investor Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ron
Both or Grant Stude<BR>
CMA Investor Relations<BR>
Tel (949) 432-7566</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email
Contact</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !+ ?X# 2(  A$! Q$!_\0
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M[;_GXB_[[% $U%-26.4$QNK@=2IS36N($8J\T:L.H+ &@"2BH?M=M_S\1?\
M?8J565U#*P8'N#F@!:**1F5%+,P51R23@"@!:*IQ:MIT\OEQ:A:R2=-J3*3^
M6:N4 %%->1(EW2.J#IECBA'21=R,K+ZJ<B@!U%%0W%W;6D?F7-Q%"G]Z5PH_
M,T 3455MM2L+UBMK>VT[#M%*K?R-6J "BD)"@DD #DDTV.:.7/ER(^.NU@<4
M /HHIDDL<6/,D1,]-QQF@!]%('5E#*P*GH0>*4$$9!S0 4444 %%%(2%!+$
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M?@/_ ,C3?_\ 8/\ _9UKV/Q=H*>)?"U_I9 \R6,F)C_#(.5/Y@4 4OA[K_\
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MD^O Q9U#M2OFL1:;4#^?<I <G& V>:N2/Y<3OC.U2<56O[%;X6VZ0IY$Z3C
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M&*:TM-3:"QE9F\L0@R1!B2P1\\#).,@XSQVQKP01VUO%;PH$BB0(BCLH& *
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MPHHHH.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
